Veradigm (NASDAQ:MDRX) Shares Down 2.7% – What’s Next?

by · The Markets Daily

Veradigm Inc. (NASDAQ:MDRX – Get Free Report) dropped 2.7% during trading on Thursday . The company traded as low as $9.05 and last traded at $9.05. Approximately 26,198 shares traded hands during trading, a decline of 98% from the average daily volume of 1,458,157 shares. The stock had previously closed at $9.30.

Analyst Ratings Changes

Separately, StockNews.com began coverage on Veradigm in a report on Thursday, December 19th. They issued a “hold” rating for the company. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $11.75.

View Our Latest Research Report on MDRX

Veradigm Price Performance

The company has a 50-day moving average price of $9.99 and a 200-day moving average price of $9.73.

Institutional Trading of Veradigm

A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC acquired a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Recommended Stories